MIRA Pharmaceuticals Inc. (NASDAQ: MIRA)
$0.78
-0.0290 ( -3.58% ) 127.1K
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Market Data
Open
$0.78
Previous close
$0.81
Volume
127.1K
Market cap
$12.11M
Day range
$0.74 - $0.83
52 week range
$0.51 - $7.98
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Aug 31, 2023 |
4 | Insider transactions | 1 | Aug 24, 2023 |
4 | Insider transactions | 1 | Aug 21, 2023 |
4 | Insider transactions | 1 | Aug 21, 2023 |
4 | Insider transactions | 1 | Aug 21, 2023 |
4 | Insider transactions | 1 | Aug 21, 2023 |
8-k | 8K-related | 18 | Aug 07, 2023 |
4 | Insider transactions | 1 | Aug 04, 2023 |
3 | Insider transactions | 2 | Aug 02, 2023 |
3 | Insider transactions | 2 | Aug 02, 2023 |